Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: Long-term results of the German CAO/ARO/AIO-94 phase III trial
نویسندگان
چکیده
منابع مشابه
Intensified neoadjuvant radio-chemotherapy for locally advanced rectal cancer: mono-istitutional experience and long-term results
Background: Purpose: The purpose of our study is to demonstrate that intensified neoadjuvant chemo-radiotherapy (CRT) treatment in locally advanced rectal cancer (LARC), aimed at further enhancing the complete pathological response and local disease control, is feasible and well tolerated. Materials and Methods: From January 2011 to December 2015, 62 patients (women 21, men 41, mean age 61,5, ...
متن کاملAdjuvant radiochemotherapy for rectal cancer.
One of the basic questions for radiation oncologists is what we hope to achieve from treatments that are adjuvant to surgery. Can we achieve a better local control? Is there a decrease in metastatic disease? Can we see an effect on overall survival? Although some questions remain to be answered, some general recommendations for the treatment of rectal cancer can be given. Since the NIH recommen...
متن کاملLong-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
BACKGROUND This study evaluated the effectiveness and safety of preoperative chemoradiotherapy with capecitabine in patients with locally advanced resectable rectal cancer. This report summarizes the results of the phase II study together with long-term (5-year) follow-up. METHODS Between June 2004 and January 2005, 57 patients with operable, clinical stage II-III adenocarcinoma of the rectum...
متن کاملPostoperative radiochemotherapy for gastric adenocarcinoma: long term results
In Slovenia as well as worldwide, gastric carcinoma is considered as a disease with poor prognosis. Radical surgery which can be performed in only 50-70% of patients1,2 is a common treatment for localized disease. Long-term outcomes with surgery alone are still relatively poor because disease recurrence was observed in 75% of patients, and in 40-65% of them, the disease recurred Received 21 Aug...
متن کاملDoes the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials
Purpose. The addition of cetuximab to radiochemotherapy (RCT) failed to improve complete response rates in locally advanced rectal cancer (LARC). We report the long-term results in patients treated within two sequential clinical trials. Methods. Patients receiving neoadjuvant RCT using capecitabine and irinotecan (CapIri) within a phase I/II trial or CapIri + cetuximab within a phase II trial w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2013
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2013.05.009